TLDR:
- Costa Mesa-based venture capital firm CerraCap Ventures has invested in Swedish company Acorai, which develops non-invasive heart failure monitoring devices.
- The size of the investment has not been disclosed.
Venture capital investor CerraCap Ventures has announced its investment in Swedish company Acorai, which specializes in developing non-invasive heart failure monitoring devices. The size of the investment has not been disclosed. CerraCap Ventures, based in Costa Mesa, California, focuses on investments in the healthcare sector. The firm, led by Founder and Managing Partner Saurabh Ranjan, is known for its strategic investments in various healthcare startups around the world.
